Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07806695
PHASE1

Islet Function in Gestational Diabetes

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-09

Completion Date

2030-12

Last Updated

2026-09-08

Healthy Volunteers

No

Interventions

DRUG

Exendin 9-39

Exendin 9-39 will be administered during one postpartum study day as an intravenous infusion at 300 pmol/kg/min for 4 hours, beginning 60 minutes before the graded glucose infusion and continuing through the end of the 180-minute glucose infusion study period

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States